With a clear commitment to research and health science, Chancellor Angela Merkel opened the new MDC research building for the Berlin Institute for Molecular Systems Biology in Berlin Mitte. She emphasized the importance of cooperation across...More
Harnessing the structural plethora of peptides to discover novel therapeutics.
3B Pharmaceuticals GmbH (3BP), a private German biotechnology company today announced a multi-year collaboration in the field of peptide-led drug discovery with...More
Apply for individual support to enter the Japanese or Korean life science market successfullyMore
Bayer’s darolutamide plus androgen deprivation therapy (ADT) significantly extends metastasis-free survival with a favorable
safety profile compared to placebo plus ADT in non-metastatic castration-resistant prostate cancer
inDemand is a new model where Healthcare organizations and companies co-create Digital Health solutions, with the economic support of public regional funds. This EU project is currently being developing in three pilot regions: Murcia (Spain), Paris...More
W&W brandpool Joins Kinderheldin’s Investor Base
American Society of Clinical Oncology Genitourinary Cancers Symposium (ASCO GU) 2019More
Asahi Kasei Pharma to Solicit Proposals for Drug Discovery Research
Asahi Kasei Pharma is publicly calling for new proposals related to drug development research as part its efforts for open innovation, to promote pharmaceutical research and...More
Shifting from treating symptoms to curing diseases and making Europe the world leader in Advanced Therapies is the aspiration of RESTORE – the Large-Scale Research Initiative, led by Charité. On February 8, the European Commission (EC) backed that...More
If awarded, you will:
- Co-develop and validate the solution within the GHU Paris, GCSMS 91 or FOCH Hospital and GIP RESAH.
- Receive funding up to 60.000€ [40.000€ for Challenges 1 to 4 and 60.000€ for Challenge 5, completed with a maximum funding...